PCT at a glance
PureCycle Technologies, Inc. (PCT, SEC CIK 1830033) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 31, 2026 and Form 4 insider filings as recently as September 25, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), PureCycle Technologies, Inc. (PCT) reported revenue of $8.4 million and a net loss of $182.6 million. Diluted EPS was -$1.21.
- As of June 30, 2026, 31 institutional investment managers tracked by SignalX reported holding PureCycle Technologies, Inc. (PCT) shares worth $323.5 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Musa Fernando on September 4, 2026 of 15,479 shares at $6.38 per share.
- In the last 90 days, PCT insiders reported 1 open-market purchase ($99K) and 0 open-market sales ($0) on Form 4, a net purchase of $99K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $8.4M
- 10-K XBRL
- Insiders · 90 days
- 1 buy · 0 sells
- Net +$99K
- 13F holders
- 31 funds
- $323.5M · +2 vs prior quarter
- Latest 8-K
- Aug 31, 2026
- Item 1.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Operating cash outflow $92.7M vs $75.6M, an unfavorable $17.1M change
- Investing cash outflow $81.0M vs $23.6M, including $35.2M capital expenditures
- Financing inflows $183.0M vs $355.6M, including $287.5M convertible-note proceeds and $163.0M stock-offering proceeds
- Ending cash, cash equivalents and restricted cash $177.3M vs $297.9M year earlier
- Capital deployment included $241.1M Green Convertible Note repurchases and $2.1M Ironton Turnaround spending
Risk Factors
- June 2026 offerings triggered expanded risk disclosures through a June 11, 2026 Form 8-K
- Ironton Facility execution risk from filter fouling, quality issues, and downtime threatening production targets and future financing
- Cybersecurity exposure heightened by enhanced disclosure requirements and evolving AI-related compliance obligations
- Total indebtedness $470.2 million as of June 30, 2026, with covenant breaches potentially accelerating maturities
- PureFive resin concentration leaves PCT dependent on a single facility and primary revenue source
AI summary of the PCT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 1.01: Entry into a Material Definitive Agreement
- $200 million revolving credit facility maturity extended one year, from September 30, 2027 to September 30, 2028
- Maturity extension fee creates an incremental financing cost for PureCycle
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026, released August 6, 2026
- Financial figures and management commentary contained in Exhibit 99.1 press release
Item 7.01: Regulation FD Disclosure
- Investor presentation scheduled for August 6, 2026, signaling an upcoming management update
- Exhibit 99.2 contains the substantive disclosure and may shape investor expectations across PCT securities
Item EX-99.1: Item EX-99.1
- Q2 revenue $4.5M, up 173% YoY, supported by first P&G deliveries and six new commercial partnerships
- Commercial adoption advancing: seven customer conversions, Downy caps in production, Tide caps targeted for Q3 retail production
Item 2.03: Creation of a Direct Financial Obligation
- June 15, 2026 closing of offerings created new financial obligations for PureCycle Technologies
- Portion of offering proceeds used to repurchase Green Convertible Notes
Item EX-99.1: Item EX-99.1
- $432.5M net proceeds from $287.5M convertible notes and 19.854M common shares
- 4.75% notes mature July 2032, replacing higher-cost 7.25% Green Convertible Notes
Item 1.01: Entry into a Material Definitive Agreement
- $441.7M gross capital raised: $287.5M convertible notes plus 19.85M shares at $8.21
- Net proceeds of approximately $432.5M, providing substantial liquidity for operations and strategic investment
AI summaries of PCT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for PCT
Don't miss the next PCT filing
- Alerts as it files. A push when PCT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut PCT, by share count.
- Ask anything. An AI agent that reads every PCT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Kalter Brad | F | Sep 23, 2026 | 2,830 | $5.15 |
| Musa Fernando | Buy | Sep 4, 2026 | 15,479 | $6.38 |
| Kalter Brad | O | Aug 24, 2026 | 50,000 | - |
| Olson Dustin | F | Aug 5, 2026 | 11,149 | $6.87 |
| SYLEBRA CAPITAL LLC | D | Jun 15, 2026 | - | $1050.00 |
| Carpenter Donald | F | May 20, 2026 | 3,017 | $11.86 |
| Olson Dustin | F | May 20, 2026 | 2,141 | $11.86 |
| Coombs Daniel M | A | May 12, 2026 | 16,622 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $0 | $0 | $8.4M |
| Operating Income | -$113.9M | -$145.4M | -$181.4M |
| Net Income | - | -$289.1M | -$182.6M |
| Op. Margin | - | - | -2171.6% |
| Net Margin | - | - | -2185.1% |
| Balance Sheet | |||
| Total Assets | - | $798.4M | $922.7M |
| Equity | $420.2M | $180.4M | $45.9M |
| ROE | - | -160.2% | -397.9% |
| Per Share | |||
| EPS | - | $-1.75 | $-1.21 |
| Cash Flow | |||
| Operating CF | - | -$144.8M | -$142.7M |
| CapEx | $153.9M | $55.6M | $40.8M |
Source: XBRL data in PureCycle Technologies, Inc. (PCT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate PCT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 31 | $323.5M |
| Q1 2026 | 29 | $189.1M |
| Q4 2025 | 26 | $368.9M |
| Q3 2025 | 28 | $570.9M |
| Q2 2025 | 25 | $560.2M |
| Q1 2025 | 20 | $186.1M |
| Q4 2024 | 19 | $243.8M |
| Q3 2024 | 15 | $81.7M |
- BlackRock+1.38M (+14%)
- Vanguard Portfolio Management LLC+921.9K (+13%)
- Vanguard Capital Management LLC+548.1K (+8%)
- Wells Fargo & Co+467.0K (+195%)
- State Street Corp+355.7K (+12%)
- Morgan Stanley−511.9K (-18%)
- Bank of America Corp−419.4K (-40%)
- Millennium Management−249.7K (-63%)
- Goldman Sachs Group−220.5K (-39%)
- Marex Group plc−110.0K (-68%)
- Two Sigma Investments+41.8K
- Blackstone Group+26.9K
- Principal Financial Group+11.2K
- Soros Fund Management−20.8K
Source: 13F-HR filings on SEC EDGAR (aggregated from 193 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
PCT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 25, 2026 | - | - | - |
| 4 | Sep 8, 2026 | - | - | - |
| 8-K | Aug 31, 2026 | - | Analysis | - |
| 4 | Aug 25, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 4 | Jul 23, 2026 | - | - | - |
| 4 | Jun 16, 2026 | - | - | - |
| 8-K | Jun 15, 2026 | - | Analysis | - |
| 8-K | Jun 11, 2026 | - | Analysis | - |
| 4 | May 21, 2026 | - | - | |
| 4 | May 21, 2026 | - | - | |
| 4 | May 13, 2026 | - | - | |
| 4 | May 13, 2026 | - | - | |
| 8-K | May 11, 2026 | - | Analysis | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 8-K | Apr 17, 2026 | - | Analysis | - |
| 4 | Mar 24, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 8-K | Mar 20, 2026 | - | - | - |
| 4 | Mar 3, 2026 | - | - | - |
| 4 | Mar 2, 2026 | - | - | - |
| 4 | Mar 2, 2026 | - | - | - |
Related Health Care companies
- ASIX · AdvanSix Inc.Plastic Materials, Synth Resins & Nonvulcan Elastomers
- ROG · ROGERS CORPPlastic Materials, Synth Resins & Nonvulcan Elastomers
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
PCT SEC filings: frequently asked questions
Are PCT insiders buying or selling?
In the last 90 days, PureCycle Technologies, Inc. (PCT) officers, directors and 10% owners reported 1 open-market purchase worth $98,756 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold PCT stock?
As of June 30, 2026, the largest PureCycle Technologies, Inc. (PCT) holders among the 13F filers tracked by SignalX were BlackRock ($90.0 million), Vanguard Portfolio Management LLC ($64.4 million), Vanguard Capital Management LLC ($60.9 million), State Street Corp ($27.0 million), Morgan Stanley ($19.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was PCT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), PureCycle Technologies, Inc. (PCT) reported revenue of $8.4 million and a net loss of $182.6 million. Diluted EPS was -$1.21. The figures come from the XBRL data in the 10-K.
What did PCT report in its latest 8-K?
PureCycle Technologies, Inc. (PCT) filed an 8-K on August 31, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). $200 million revolving credit facility maturity extended one year, from September 30, 2027 to September 30, 2028.
What are the latest PCT SEC filings?
PureCycle Technologies, Inc. (PCT) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 31, 2026 and a Form 4 insider filing on September 25, 2026.
What is PCT's SEC CIK number?
PureCycle Technologies, Inc. (PCT)'s SEC Central Index Key (CIK) is 1830033. EDGAR lists every PCT filing under that number.
Ask anything about PCT
The research agent reads PCT's filings, financials, insider trades and 13F holders, then answers with sources.